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Abstract: Toxoplasma gondii is a leading cause of foodborne illness and consumption of undercooked
pig meat is a major risk factor for acquiring toxoplasmosis, which causes a substantial burden on
society. Here, we used isobaric tags for relative and absolute quantification (iTRAQ) labelling coupled
with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify cellular proteins and
pathways altered during T. gondii infection in pigs. We also used parallel reaction monitoring-based
LC-MS/MS to verify the levels of protein expression of infected spleens and mesenteric lymph
nodes (MLNs). At 6 days post-infection (dpi), 156, 391, 170, 292, and 200 differentially expressed
proteins (DEPs) were detected in the brain, liver, lung, MLNs and spleen, respectively. At 18 dpi, 339,
351, 483, 388, and 303 DEPs were detected in the brain, liver, lung, MLNs and spleen, respectively.
Although proteins involved in immune responses were upregulated in all infected tissues, protein
expression signature in infected livers was dominated by downregulation of the metabolic processes.
By weighted gene co-expression network analysis, we could further show that all proteins were
clustered into 25 co-expression modules and that the pink module significantly correlated with the
infection status. We also identified 163 potential anti-T. gondii proteins (PATPs) and provided evidence
that two PATPs (HSP70.2 and PDIA3) can reduce T. gondii burden in porcine macrophages in vitro.
This comprehensive proteomics analysis reveals new facets in the pathogenesis of T. gondii infection
and identifies key proteins that may contribute to the pig’s defense against this infection.
Keywords: Toxoplasma gondii; pigs; proteome; immune proteins; co-expression
1. Introduction
Toxoplasmosis, a widespread zoonosis, is caused by the opportunistic protozoan parasite
Toxoplasma gondii. This parasite has a remarkable ability to infect almost all warm-blooded vertebrates [1].
Humans and animals acquire T. gondii through ingestion of undercooked or raw meat containing
bradyzoites within cysts or drinking water contaminated with sporulated oocysts. Tachyzoite is
another infective stage of T. gondii and differentiates into bradyzoite at 10–14 days post infection [2].
T. gondii infection is often benign in immunocompetent individuals. However, reactivation of latent
infection in immunocompromised patients can cause brain abscesses, encephalitis and chorioretinitis,
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and primary infection during pregnancy can lead to abortion or severe health consequences (e.g. ocular
impairment and neurological sequelae) in prenatally affected children [3]. The presence of T. gondii
cysts in the brain has also been associated with altered predator aversion of murine hosts toward
cats [4,5], and neuropsychological conditions, such as schizophrenia in humans [6–8]. Chronic T. gondii
infection can even alter subpopulations of neurons in pigs [9].
Although mice have been used as a powerful model to investigate the molecular pathophysiology
of toxoplasmosis, biological differences exist between mice and humans, in terms of susceptibility to
and immune response against T. gondii infection [10–12]. Pigs are anatomically and physiologically
similar to humans [13], and their susceptibility to infection is more similar than that of mice [14].
Therefore, a pig model of infection would be relevant for investigating the determinants of T. gondii
pathogenesis. The significant role of pigs in the transmission of T. gondii infection to humans [15,16] is
another reason to understand the mechanism of toxoplasmosis disease in this animal species.
T. gondii has the capability to coordinate host gene expression and evade several immune defense
mechanisms in order to establish acute or chronic infection within the host [17–20]. Proteomic analysis
has also revealed many host proteins that play a role in the mouse response to T. gondii infection [17].
The proteome links phenotype to genotype and its investigation can reveal many molecular events
that influence host cellular mechanisms during infection [21]. However, how the T. gondii infection
reshapes protein expression of porcine tissues during T. gondii infection remains largely unknown.
In the present study, we used a quantitative proteomics approach to investigate the effect of T. gondii
infection on the proteome of multiple tissues of pigs. We employed tandem mass spectrometry because
it enables a global understanding of the function and regulation of the proteome [22]. Bioinformatics
analysis was performed to identify the differentially expressed proteins (DEPs), which can play
a role in the pathophysiology of T. gondii infection. Additionally, seven DEPs were selected for
parallel reaction monitoring (PRM) analysis in order to verify the expression results obtained by mass
spectrometry analysis.
2. Materials and Methods
2.1. Animals, Parasite Challenge, Sample Collection and T. gondii Detection
Specific-pathogen-free (SPF) white pigs were purchased from Beijing Center for SPF Swine
Breeding and Management. All pigs were handled strictly in accordance with the Animal Ethics’
Procedures and Guidelines of the People’s Republic of China. The study design was reviewed and
approved by the Animal Ethics Committee of Lanzhou Veterinary Research Institute, Chinese Academy
of Agricultural Sciences. The sera of all pigs were screened for anti-T. gondii antibodies using a modified
agglutination test (MAT). The pigs used in the study were seronegative for T. gondii.
The study included 24 pigs divided into eight groups (3 pigs/group): 6C_1 (Control group
slaughtered at 6 days post infection [dpi], replicate 1), 6C_2 (Control group slaughtered at 6 dpi,
replicate 2), 18C_1 (Control group slaughtered at 18 dpi, replicate 1), 18C_2 (Control group slaughtered
at 18 dpi, replicate 2), 6T_1 (Treatment group slaughtered at 6 dpi, replicate 1), 6T_2 (Treatment group
slaughtered at 6 dpi, replicate 2), 18T_1 (Treatment group slaughtered at 18d dpi, replicate 1), and 18T_2
(Treatment group slaughtered at 18 dpi, replicate 2). In the infected groups, each pig was inoculated
orally with 1000 oocysts of T. gondii PYS strain (genotype ToxoDB#9) mixed with 100 g pig feed in 5 mL
sterile phosphate-buffered saline (PBS). Each pig in the control groups was mock inoculated with 100 g
pig feed mixed with 5 mL sterile PBS. Brains (cerebral cortices), livers, spleens, lungs and mesenteric
lymph nodes (MLNs) of pigs were collected at 6 and 18 dpi. The collected tissues were stored frozen at
−80 ◦C until used for proteomic analysis and DNA extraction.
For in vitro experiment, 3D4/2 cell lines were challenged with T. gondii tachyzoites at multiplicity
of infection (MOI) of 1. After 48 h, the infected cells were collected, and their DNAs were extracted
for detection of relative T. gondii load. Genomic DNA was extracted using TIANamp Genomic DNA
Kit (Tiangen Biotech, Beijing, China) according to the manufacturer’s instructions and stored frozen
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at −20 ◦C until use. The T. gondii B1 gene was used for T. gondii detection and quantification, and
the pig 18S rRNA gene was used to normalize T. gondii B1 DNA to host DNA. The primers used
for T. gondii B1 gene detection/quantification were: B1F: TGCATAGGTTGCAGTCACTG and B1R:
TCTTTAAAGCGTTCGTGGTC (the expected product size is 131 bp). The primers used for pig DNA
normalization were: 18S-pigF: GCCTGCTGCCTTCCTTG and 18S-pig: ATGGTAGTCGCCGTGCC
(the expected product size is 109 bp). Quantitative real time polymerase chain reaction (q-PCR) was
performed on the Rotor-Gene Q (QIAGEN, Hilden, Germany) using SYBR Green GoTaq qPCR Master
Mix (Promega, Beijing, China) according to the manufacturer’s instructions. SYBR Green q-PCR cycling
conditions included 95 ◦C for 5 min followed by 50 cycles of 95 ◦C for 10 s, 60 ◦C for 10 s, and 72 ◦C for
15 s. The temperature of melting curve analysis ranged from 72 ◦C to 95 ◦C to ensure specificity of the
qPCR products. The 2-∆∆CT relative expression method was used for the calculation of the relative
T. gondii load [23].
2.2. Protein Extraction and iTRAQ Analysis
Protein extraction and iTRAQ labeling were performed as previously described [17]. Briefly, pig
tissues were individually ground into powder using liquid nitrogen, and protein was extracted with
lysis buffer (4% CHAPS, 7M Urea, 1 mM PMSF, 40 mM Tris-HCl, 2M Thiourea, 2 mM EDTA, pH 8.5).
Protein quantification was measured by using Bradford assay [24]. The extracted proteins were kept at
–80 ◦C until used for iTRAQ analysis. Before iTRAQ labeling, an equal amount of protein from each
sample of the same group were pooled as one replicate. For each pooled replicate, ~100 µg protein was
digested with Trypsin Gold (Promega, Madison, WI, USA) at an enzyme-protein ratio of 1:30 (w/w) at
37 ◦C for 16 h. The resulting peptides were dried by vacuum centrifugation and reconstituted in 0.5 M
triethyl ammonium bicarbonate (TEAB) (Thermo Fisher Scientific, Inc.) and processed according to
the manufacture’s protocol for 8-plex iTRAQ reagent (Applied Biosystems). SCX chromatography
was performed with a LC-20AB HPLC Pump system (Shimadzu, Kyoto, Japan). Peptides elution was
monitored for absorbance at 214 nm, and fractions were collected every 1 min. The eluted peptides of
the same replicate were divided into 20 fractions and desalted with a Strata X C18 column (Phenomenex)
and then vacuum-dried. Each fraction was analyzed using LC-ESI-MS/MS based on Triple TOF 5600
System (AB SCIEX, Concord, ON) fitted with a Nanospray III source (AB SCIEX, Concord, ON) and a
pulled quartz tip as the emitter (New Objectives, Woburn, MA). Protein identification was achieved
using commercial Mascot search engine (Matrix Science, London, UK; version 2.3.02) against Uniprot
database and two unique peptides were required for protein identification. Student’s t-test was used for
significant expressional change analysis. The resulting dataset was auto bias-corrected to the biological
replicate, and quantitative protein ratios were weighted and normalized by the median ratio using the
Mascot software. p-values <0.05 and fold change >1.2 (upregulated) or <0.83 (downregulated) were
used as cut-off to determine proteins with significantly altered expression levels. The protein extraction,
iTRAQ analysis, protein identification and quantification were performed at BGI-Shenzhen, China.
2.3. Targeted Protein Quantification by Parallel Reaction Monitoring (PRM)
iTRAQ-based results were validated using a PRM-based LC-MS/MS approach. Seven proteins
were selected for verification, including HSP90AA1, OXCT1, ARL6IP5, GBP7, GBP1, PDIA3 and
GVIN2. The proteins of spleen and MLN samples were separately extracted as described above. The
isolated proteins were used for PRM analysis. Briefly, the extracted proteins were incubated with
10 mM dithiothreitol (DTT) (Thermo Fisher Scientific, Inc.) at 56 ◦C for 30 min, followed by incubation
with 55 mM iodoacetamide (IAM) (Promega, Madison, WI, USA) for 30 min and addition of 4-fold
volume chilled acetone and incubation at −20 ◦C overnight. This was followed by centrifugation of
the mixture and discarding of the supernatant. The protein was dissolved with 8 M urea/100 mM
TEAB (pH 8.0) (Thermo Fisher Scientific, Inc.) and quantified using the Bradford assay. Then, 100 µg
protein were digested with trypsin overnight at 37 ◦C and the protein digestion was terminated by
trifluoroacetic acid (TFA). The peptides were desalted by C18 column (Phenomenex) and vacuum
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dried. The dried peptides were subjected to LC-ESI-MS/MS analysis based on a Triple TOF 5600 System
(AB SCIEX, Concord, ON), and the PRM data were collected. The PRM experiments and data analysis
were completed by Wuhan GeneCreate Biological Engineering Co., Ltd.
2.4. Bioinformatics Analysis of Proteins
KOBAS3.0 [25] was used for Kyoto Encyclopedia of Genes and Genomes database (KEGG)
pathway enrichment analysis. Fisher’s exact test was performed to evaluate the level of significance in
the enrichment analysis. Gene Ontology (GO) enrichment analysis was performed with the threshold
of p < 0.05 for three categories biological process, molecular function, and cellular component. p-value
calculated by Fisher’s exact test was further adjusted by false discovery rate (FDR) correction [26].
FDR corrected p-values under a threshold of 0.05 were considered significant. WGCNA R package [27]
was used for protein co-expression and trait correlation analyses. In WGCNA analysis, normalized
expression of all proteins and the infection status were used as input data. The soft power detection
ranged from 1 to 20 and the lowest power at which the scale-free topology fit index reaches 0.8 was
chosen as the soft power that was used for constructing a weighted gene co-expression network.
Infection status (infected samples were assigned 1 and control samples were assigned 0) was used as
a correlative trait. For testing the predictive performance between the protein expression level and
T. gondii infection, pROC R package [28] was applied to analyze the receiver operating characteristic
curve (ROC) and area under curve (AUC) between the module genes and T. gondii infection. Proteins
interaction network was analyzed using STRING database [29].
2.5. Construction of HSP70.2- and PDIA3-Expressing Plasmids and Transfection of 3D4/2 Cells
The pig CRISPR-Cas9 plasmid was constructed as shown in Supplementary Figure S1A and was
designed with sgRNA sequence (GTTCCTGGAAGTTTAGATCA) that targets the H11 gene locus. H11
is one of the pig genome loci known as a safe harbor, in which an exogenous gene can be inserted
while circumventing potential “positional effects” and avoiding the interference in the genome. Gene
over-expression donor scaffold (H11-cmv-c-HA over-expression donor plasmid) was synthesized by
Genewiz (Genewiz, China). The complete sequence and sequence annotations of the donor plasmid are
shown in Supplementary File S1. The primers used for gene cloned into H11-cmv-c-HA over-expression
donor plasmid and knock-in detection are listed in Supplementary Table S1. The HSP70.2-expressing
plasmids were constructed as follows: the full-length (1923 bp) cDNA of target gene (HSP70.2) was
amplified from RNA extracted from the tissue of a healthy pig using RT-PCR with primers HSP70.2-F (5’-
GCGGTGGCGGCCGCTCTAGGCCACCATGGCGAAGAGCGTGGCCATCGGCAT-3’) and HSP70.2-R
(5’- ATCTGGAACATCGTATGGGTAATCCACCTCCTCGATGGTGGGGC-3’). Likewise, PDIA3 coding
sequence was amplified using primers PDIA3-F (5’- GCGGTGGCGGCCGCTCTAGGCCACCATGCG
CCTCTGCCGCCTAGCGCT-3’) and PDIA3-R (5’-ATCTGGAACATCGTATGGGTAGAGATCCTCC
TGTGCCTTCTTCT-3’). The PCR products were ligated with knock-in donor fragment using ClonExpress
MultiS One Step Cloning Kit (Vazyme Biotech Co., Ltd, China) according to the manufacturer’s
instructions. Knock-in donor fragment was amplified from H11-cmv-c-HA donor plasmid using
primers Vector-F (5’-TACCCATACGATGTTCCAGAT-3’) and Vector-R (5’-GGTGGCCTAGAGCGGCCG
CCACCGC-3’). The plasmid that was successfully constructed with target gene CDS and knock-in
donor fragment was extracted using Endofree Maxi Plasmid Kit (TIANGEN, China), and digested
using NruI enzyme for linearization of knock-in donor (named as transfection donor in Supplementary
Figure S1B). The pig CRISPR-Cas9 plasmid and linearized knock-in donor were co-transfected into
porcine macrophage cell line 3D4/2 (ATCC, CRL-2845) using XfectTM Transfection Reagent (Takara,
China). Forty-eight hours post transfection, transfected cells were selected with 2 µg/mL puromycin,
10% fetal bovine serum (FBS), 90% high glucose DMEM/F12 for 4 days. The puromycin-resistant cells
were plated in limiting dilution in 96-well plates for isolation of single clones. The genomic knock-in
was validated by PCR using primers Knock-in-F and Knock-in-R (Supplementary Table S1).
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2.6. Validation of the Expressed Proteins
Western blotting analysis was performed to examine whether knock-in genes were correctly
expressed in the 3D4/2 cells. The total proteins were extracted from transfected cells using
ProteinExt®Mammalian Total Protein Extraction Kit (Transgene, China). Approximately 30 µg total
protein and 10 µL Blue plus IV Protein Marker (Transgen, China) were loaded on 12% ExpressplusTM
PAGE Gels (GenScript, China) and electrophoresis was run at 100V for 1.5 h. The proteins were
electrically transferred to PVDF membrane (Thermo, Germany) at 20V for 30 min using Trans-Blot SD
apparatus (Bio-Rad, USA), and then blocked with 5% fat-free milk for 1 h. The PVDF membrane was
incubated with primary anti-HA tag antibody (Abcam, UK) at 4 ◦C overnight and then washed three
times with tris-buffered saline (TBS). The PVDF membrane was then incubated with goat anti-mouse
IgG H&L (HRP) antibody (Abcam, UK) at 37 ◦C for 1 h. The PVDF membrane was washed three
times using TBS buffer and incubated with the ECL reagent (Solarbio, China) for chemiluminescence
detection. The images were obtained by X-ray film (Carestream, China).
We also performed immunofluorescence analysis of the over-expressed proteins. Wild type 3D4/2
cells and protein over-expressing cells were grown on coverslips and challenged with T. gondii at
multiplicity of infection (MOI) of 1. After 48 h, infected cells were washed three times with PBS and
fixed with 4% paraformaldehyde in PBS (Solarbio, China) for 10 min. The fixed cells were washed
with PBS three times and permeabilized with 0.1% TritonX-100 (Beyotime, China) for 20 min. The
cells were blocked with 5% bovine serum albumin for 1 h and washed with PBS for three times. The
cells were incubated with primary mouse anti-HA tag antibody (Abcam, UK) overnight at 4 ◦C. The
cells were washed three times with PBS and the parasites were detected with primary anti-T. gondii
antibody (FITC) (Abcam, UK), followed by goat anti-mouse IgG H&L secondary antibody, conjugated
with Alexa Fluor®647 (Abcam, UK) at 37 ◦C for 2 h. The cell nucleus was stained with 100 ng/mL
DAPI (Invitrogen) for 10 min. The coverslips were placed on a glass slide in mounting medium
(Solarbio, China) and examined with a confocal laser scanning microscopy platform Leica TCS SP8
(Leica, Germany).
3. Results
3.1. Confirmation of T. gondii Infection
All pigs in the infected groups showed clinical signs at 6 dpi, such as fever and inappetence,
whereas pigs in the control groups remained apparently healthy. PCR results showed that all collected
tissues of infected groups were T. gondii B1 gene positive. However, the tissues of control groups were
B1 gene negative.
3.2. Proteomic Features of Infected Tissues
Our analysis revealed 4706, 4224, 4535, 5103 and 4414 proteins in pig brain (cerebral cortex), liver,
lung, MLNs and spleen, respectively. More than 300,000 spectra were obtained in each tissue. The
summary of protein identification data is shown in Supplementary Table S2. Most mean variation
coefficients (CV) were <0.1, and >90% of the proteins had CV < 0.3, indicating that our iTRAQ analysis
had good repeatability and performance (Supplementary Table S3). At 6 dpi, 108, 125, 109, 163, and
140 DEPs were upregulated, whereas 48, 266, 61, 129, and 60 DEPs were downregulated in infected
brain, liver, lung, MLNs and spleen, respectively. At 18 dpi, 202, 171, 233, 159, and 141 DEPs were
upregulated, but 137, 180, 250, 229, and 162 DEPs were downregulated in infected brain, liver, lung,
MLNs and spleen, respectively (Figure 1A). No common DEP was found among the tissue groups
examined (Supplementary Figure S2). To validate the expression data, targeted mass spectrometry
analysis using PRM was performed. As shown in Supplementary Figure S3, PRM expression data of
seven selected proteins (HSP90AA1, OXCT1, ARL6IP5, GBP7, GBP1, PDIA3 and GVIN2) of spleens
and MLNs showed similar expressional trends to iTRAQ-based mass spectrometry data. All mass
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spectrometry raw data are available at ProteomeXchange database with accession numbers: PXD011816,
PXD011828, PXD011829, PXD011830 and PXD011831.
3.3. Enrichment Analysis of Differentially Expressed Proteins (DEPs)
GO and KEGG enrichment analyses of the DEPs revealed that T. gondii infection can significantly
upregulate dozens of biological processes in infected brain at 18 dpi, such as small GTPase mediated
signal transduction, actin filament-based process, vesicle-mediated transport and antigen processing
and presentation. Only a few pathways were significantly enriched in the brain at 6 dpi. DEPs of
vesicle-related GO terms were upregulated in the infected brains (Supplementary File S2). In infected
livers, at 6 dpi and 18 dpi, the significantly altered biological processes involved downregulation
of the metabolic processes, such as oxidation-reduction process, carboxylic acid metabolic process,
oxidoreduction coenzyme metabolic process, pyruvate metabolic process, and tryptophan metabolism.
Additionally, upregulation of immune response related processes was also detected in infected liver,
especially at 18 dpi (Supplementary File S3). In the infected lung, spleen and MLNs, immune
response-related processes/pathways were significantly altered, including upregulation of antigen
processing and presentation, chaperone-mediated protein folding, complement and coagulation
cascades, response to stress, and innate immune response. The details of KEGG enrichment analysis of
DEPs (including GO annotations according to biological processes, cellular components, and molecular
functions) in infected lung, spleen and MLNs are listed in Supplementary Files S4–S6, respectively.
3.4. Co-Expression and Trait Correlation Analyses
The WGCNA R package was used for protein co-expression and trait correlation analyses.
As shown in Figure 1B, infected and non-infected tissues were separated into two main branches
according to their respective protein expression patterns. The soft power (3) was the first power value
that showed scale free topology model fit value > 0.8 (Supplementary Figure S4A). Additionally, soft
power (3) showed a relatively high gene connectivity (Supplementary Figure S4B). Therefore, the
number 3 was used as soft power for building the co-expression network. We detected 25 co-expression
modules (Figure 1C). The modules, traits and T. gondii gene significance relationship are shown in
Figure 2A,B. Pink module was significantly correlated with T. gondii infection supported by a correlation
coefficient of 0.76 and p-value of 7 × 10−8. The Pearson correlation coefficient between gene significance
and gene module membership in the pink module was 0.6 with p-value 8.1 × 10−31 (Figure 2C). Pink
module contained 301 proteins. Top 30 proteins that showed the highest gene significant for T. gondii
infection included: HSP90AA1, PLCH1, SERPINA3-3, HSPA4, GBP1, HSPCB, STIP1, TRIM21, HYOU1,
HSPA5, ITGAL, PZP, GVIN1, PDIA3, ERAP1, C3, SLA-DRA, LOC100513619, C4, GP91-PHOX, HSPH1,
PLG, GBP7, STAT3, CASP1, HSP90B1, HSPA8, PPIB, TAP1 and HSP70.2. The interaction network of the
top 30 genes is shown in Figure 2D. All top 30 genes showed excellent performance to predict T. gondii
infection as shown by AUC of all these genes (Figure 3). Table 1 shows the orthology description of the
top 30 genes. KEGG enrichment analysis of the genes in the pink module revealed that 69 pathways
were significantly enriched, such as complement and coagulation cascades, protein processing in
endoplasmic reticulum, antigen processing and presentation, phagosome, proteasome and NOD-like
receptor signaling pathway (Figure 4).
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Figure 1. Summary of the differentially expressed proteins (DEPs) and co-expression analysis of protein
expression profile. (A) The number of upregulated and downregulated proteins in each pig tissue.
(B) Sample clustering based on their protein profiles. (C) Cluster dendrogram of protein. GS weight
denotes gene significant weight.
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Figure 2. Relationship between the modules and T. gondii infection. (A) Relationship between modules
and T. gondii infection status. (B) Level of gene significance of the different modules. (C) Pearson’s
correlation coefficient between gene significance for T. gondii and module membership in the pink
module. (D) Interaction network of the top 30 hub genes.
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Figure 3. Summary of the receiver operating characteristic (ROC) analysis and associated area under the
curve (AUC). ROC curves show the correlation between the top 30 hub proteins and T. gondii infection.
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Table 1. Orthology descriptions of the top 30 genes that showed the highest T. gondii infection gene significance.
Protein Gene Significance forT. gondii Infection
Total Quant Peptide
Number Description Reference
GBP1* 0.82646008 307.2 Interferon induced guanylate binding protein 1. GBP1 contributes toanti-T. gondii. [30,31]
TRIM21* 0.806586641 27.6
Tripartite motif containing 21. TRIM21-/- mice were highly susceptible to
T. gondii infection and associated with higher T. gondii burden in the
periphery and later in the brain.
[31]
ERAP1* 0.791323457 175.2
Endoplasmic reticulum aminopeptidase 1. Polymorphism of the human
ERAP1 was significantly associate with susceptibility to human
congenital toxoplasmosis (p<0.05).
[32,33]
C3* 0.789437052 648 Complement C3 precursor. C3 participates in complement-mediatedkilling of T. gondii. [34]
C4* 0.777101166 126.25 Complement C4. Participating in antibody-dependent cytolysis ofT. gondii requires C4. [35]
GP91-PHOX* 0.768203441 57.5
Also known as NOX2. Mice deficient in NADPH oxidase isoform 2
(NOX2-/-) were not able to control T. gondii replication and produce
IL-12p40, even upon LAM treatment.
[36]
GBP7* 0.761176836 63.6
Guanylate-binding protein 7. The reintroduction of Gbp7 into




Signal transducer and activator of transcription 3. STAT3 upregulates




Caspase-1. Inflammasomes activate caspase-1, highly conserved Toxo1
haplotype directs resistance to toxoplasmosis and its associated caspase-1
dependent killing of parasite and host macrophage.
[38]
TAP1* 0.743196951 116.25 Antigen peptide transporter 1. TAP-1 regulates host ant- T. gondiiinfection by controlling NK cell IFN-γ production. [39]
ITGAL* 0.799960205 87.6
Also known as CD11A, mediating natural killer cell mediated
cytotoxicity. Expression of CD11a has been used as a marker of
activation for the polyclonal antigen-specific T cell population in a
variety of infectious settings, including toxoplasmosis.
[40,41]
HSP90AA1 0.854644744 1063.2 Also known as Hsp90. Hsp90 is an allosteric enhancer of iNOS whichregulates nitric oxide biosynthetic process. [42]
HSPA8 0.752183858 1106.4
Heat shock protein family A (Hsp70) member 8 (Also known as HSC70).
The role of this gene in T. gondii infection is unclear. However, HSC70
from human 293T cells was shown to interact with a T. gondii protein
designated T. gondii MAR domain-containing protein 4a (TgMCP4a).
[43]
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Table 1. Cont.
Protein Gene Significance forT. gondii Infection
Total Quant Peptide
Number Description Reference
STIP1 0.807262519 285.6 Stress induced phosphoprotein 1. Participating in protein correct folding. NCBI annotation
PLCH1 0.854138738 21.25 Phospholipase C eta 1. Participating in inositol phosphate metabolism. NCBI annotation
SERPINA3-3 0.853359004 272.4 SERPINA3-3 participates in innate immune system and plateletactivation. NCBI annotation
HSPA4 0.834185425 356.4 Heat shock protein family A (Hsp70) member 4. Participating in antigenprocessing and presentation. NCBI annotation
HSPCB 0.815171015 538.8
Also known as Heat shock protein 90 alpha family class B member 1
(HSP90AB1). Participates in antigen processing and presentation, and
protein processing in endoplasmic reticulum.
NCBI annotation
HYOU1 0.805621318 457.2 Hypoxia upregulated protein 1 (Also known as GRP170). Regulatingprotein processing in endoplasmic reticulum. NCBI annotation
HSPA5 0.801396263 1140
Heat shock protein 5. (Also known as BIP). Participating in antigen
presentation, protein folding, protein assembly and peptide loading of
class I MHC.
NCBI annotation
PZP 0.797371798 489.6 PZP has endopeptidase inhibitor activity. NCBI annotation
GVIN1 0.796028791 150 Interferon-induced very large GTPase 1. GTPase participates inanti-T. gondii. However, its role in T. gondii infection still unclear. NCBI annotation
PDIA3 0.794989508 1144.8
Protein disulfide isomerase family A member 3. Participating in antigen
presentation, protein folding, protein assemble and peptide loading of
class I MHC
NCBI annotation
SLA-DRA 0.788350216 78 MHC class II DR-alpha. Participating in antigen processing andpresentation. NCBI annotation
LOC100513619 0.779559416 310.8 E3 ubiquitin-protein ligase RNF213-like. NCBI annotation
HSPH1 0.764095739 325.2 Heat shock protein family H (Hsp110) member 1. Participating in proteinprocessing in endoplasmic reticulum. NCBI annotation
PLG 0.763548077 28.8 Plasminogen. Involved in complement and coagulation cascades. NCBI annotation
HSP90B1 0.752494384 892.8 Heat shock protein 90 beta family member 1 participates in proteinprocessing in endoplasmic reticulum. NCBI annotation
PPIB 0.747401536 140.4 Peptidylprolyl isomerase B (PPIB) participates in extracellular matrixorganization. NCBI annotation
HSP70.2 0.743037358 236.4
Heat shock 70 kDa protein 1B. Participates in antigen processing and
presentation, innate immune system and protein processing in
endoplasmic reticulum.
NCBI annotation
Note: * indicates that the protecting role has been confirmed.
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Figure 4. Kyoto Encyclopedia of Genes and Genomes database (KEGG) enrichment analysis of genes
in the pink module.
3.5. Identification and Functional Analysis of Potential Anti-T. gondii Proteins (PATPs)
The pink module was highly correlated with T. gondii infection. It is sensible to anticipate that
the gene that has an anti-T. gondii property should be highly correlated with T. gondii infection and
upregulated in infected tissues. As shown in Figure 5A, the proteins in the pink module were categorized
into upregulated branch and downregulated branch. Therefore, the genes in the upregulated branch
were identified as PATPs that could contribute to anti-T. gondii processes. Details of these PATPs are
listed in Supplementary File S7. By analyzing the gene locations of PATPs, we found that chromosome
7 has two T. gondii hotspots that showed high density of PATPs (Figure 5B, Table 2). Most genes in the
two hotspots participate in antigen presentation or other immune-related pathways (Table 2). Two hub
proteins of the top 30 genes (Figure 2D) were identified as PATPs (HSP70.2 and PDIA3) because they
were highly expressed and were thus selected for functional validation. PCR amplification of porcine
H11 locus showed that, as expected, PDIA3 and HSP70.2 over-expression cassette was successfully
inserted into H11 locus as shown by a fragment size of about 6,400–6,800 bp, while wild type 3D4/2 cell
line showed normal size (1,878 bp) (Figure 5C). The PCR product size was consistent with the expected
size, suggesting that HSP70.2 or PDIA3 over-expression element was correctly inserted into H11 locus.
However, HSP70.2 over-expression element was only inserted into one of the two allelic H11 locus.
Western blotting result showed that the product of HSP70.2 over-expressing cells was about 52.8 KD,
and the product of PDIA3 over-expressing cells was about 56.9 KD. The over-expressed HSP70.2 and
PDIA3 proteins are consistent with the predicted sizes (Figure 5D). The two protein over-expressing cell
lines showed lower T. gondii loads compared with wild type 3D4/2 macrophages (Figure 5E). Pathway
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enrichment analysis was performed to analyze the functions of the significantly enriched genes in
the downregulated (139 proteins) and the upregulated branch (163 proteins). As shown in Figure 6,
genes in the downregulated branch were enriched in metabolism, cell migration, cell interaction and
other related pathways. However, the genes in the upregulated branch were enriched in immune
response, pathogen infection and other related pathways. The immunofluorescence analysis results
also confirmed that HSP70.2 and PDIA3 were successfully expressed in the 3D4/2 cells (Figure 7).
Figure 5. Clustering of genes in the pink module and the potential anti-T. gondii proteins (PATPs).
(A) Clustering of the genes in the pink module. (B) Genomic distribution of PATPs. Red circles enclose
hotspots of the chromosome 7. (C) Polymerase chain reaction (PCR) detection of H11 locus of HSP70.2
or PDIA3 over-expressing elements. Abbreviations: m: DNA marker DL15000; n: wild type 3D4/2
cell line; h, HSP70.2 over-expressing cell line; p, PDIA3 over-expressing cell line. (D) Western blot
analysis of HSP70.2 and PDIA3 in the two over-expressing cell lines. (E) Relative T. gondii load in the
two over-expressing cell lines.
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Figure 6. KEGG enrichment analysis of the genes in the two branches of the pink module.
Figure 7. Immunofluorescence analysis of transgenic 3D4/2 cells stably overexpressing (OE) HSP70.2
and PDIA3 genes compared to control (wild type) cells. Images show 3D4/2 cells expressing high levels
of HSP70.2 and PDIA3 proteins.
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Table 2. Details of the potential anti-T. gondii proteins hotspots in chromosome 7.
Protein Description Chromosome Start Chromosome End Pathway
SLA-1 MHC class I antigen 1 24748096 24751686 Antigen processing and presentation NCBI annotation
C4 Complement C4A 27729074 27744209 Complement and coagulation cascades NCBI annotation
CFB Complement factor B 27771678 27777773 Complement and coagulation cascades NCBI annotation
SLA-DRA MHC class II DR-alpha 29036552 29042147 Antigen processing and presentation NCBI annotation
SLA-DQB1 SLA-DQ beta1 domain 29180534 29188739 Antigen processing and presentation NCBI annotation
TAP2 Transporter 2, ATP binding cassette subfamily B member 29256675 29268410 Antigen processing and presentation NCBI annotation
TAP1 Transporter 1, ATP binding cassette subfamily B member 29274670 29283290 Antigen processing and presentation NCBI annotation
LOC100520085 proteasome subunit beta type-9 29283635 29288788 Antigen processing-Cross presentation NCBI annotation
TAPBP TAP binding protein 34167262 34176573 Antigen processing and presentation NCBI annotation
SERPINA3-3 SERPINA 3-3 122823963 123025049 Innate Immune System NCBI annotation
LOC100153899 Serpin A3-8 122961721 122969848 Innate Immune System NCBI annotation
LOC100156325 Serpin A3-6 123094660 123103381 Innate Immune System NCBI annotation
SERPINA3-2 Alpha-1-antichymotrypsin 2 123110533 123119651 Innate Immune System NCBI annotation
WARS Tryptophanyl-tRNA synthetase 128677568 128702987 Tryptophanyl-tRNA synthetase NCBI annotation
HSP90AA1 Heat shock protein 90 alpha family class A member 1 129758754 129760542 Regulation of eNOS activity NCBI annotation
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4. Discussion
The present study is the first to provide a comparative analysis of the proteomic response of five
swine tissues to T. gondii infection using iTRAQ-based quantitative proteomic approach. Our analysis
identified many altered cellular pathways and DEPs during T. gondii infection. To verify the results
obtained by mass spectrometry analysis, expression profiles of seven proteins in infected spleens and
MLNs, including four PATPs (HSP90AA1, GBP1, PDIA3 and GBP7) and three non-PATPs (OXCT1,
ARL6IP5 and GVIN2), were examined using targeted PRM analysis. As shown in Supplementary
Figure S3, the expression profiles of the seven proteins were similar to the expression profiles obtained
by iTRAQ analysis, supporting the validity of the protein expression data.
GO and KEGG pathway analyses have shown that vesicle related processes were upregulated
in most infected tissues, including brain, spleen, lung and MLNs (Supplementary Files S2–S6).
However, vesicle-related processes were downregulated in infected liver at 6 dpi (Supplementary
File S3), which disagrees with upregulation of the vesicle-related processes detected previously in
the liver of infected mice [17,44]. However, downregulation of the metabolic process of infected
pig liver in the present study was also observed in the mouse model [17,44]. About 190 proteins,
involved in metabolic processes, were differentially expressed in the infected livers, most of them
downregulated (Supplementary File S3). This suggests that downregulation of the metabolism could
be ubiquitous in the liver during T. gondii infection. On the contrary, in all infected tissues, immune-
or infection-related pathways were upregulated, including upregulation of antigen processing and
presentation, chaperone-mediated protein folding, and complement and coagulation cascades. This
suggests that anti-T. gondii mechanisms were activated and some of these could be common between
different tissues and important for helping the swine host to counter T. gondii in vivo.
Although we found >100 DEPs in infected tissues (Figure 1A), after intersecting the DEP sets
across tissues, there was not any DEP shared across all tissues as shown in the vertical bars and the
connected black circles below the histogram (Supplementary Figure S2). Co-expression and trait
correlation analysis can reveal common host pathways that may contribute to countering T. gondii
infection. As shown in Figure 1B, the protein profiles of infected tissues were different from non-infected
tissues, indicating that biological responses of infected tissues have been altered by T. gondii infection.
According to the protein profile cluster dendrogram, 25 protein co-expression modules were found
(Figure 1C). Regarding correlation with infection status, we found that the pink module showed the
highest correlation with T. gondii infection. Global correlation coefficient between T. gondii infection
and pink module protein profile was 0.76 with p value 7 × 10−31 (Figure 2A). A high gene significance
was also detected in pink module protein (Figure 2B,C). As shown in Figure 2C, the global correlation
coefficient between gene module membership and gene significant for T. gondii infection was 0.6 with
the p value 8.1 × 10−31. These data indicate that proteins in the pink module are associated with
T. gondii infection.
We also performed KEGG pathway enrichment analysis in order to analyze the significantly
enriched functions of the proteins in the pink module. As shown in Figure 4, the most enriched pathways
were infection, disease and immune related pathways, including complement and coagulation cascades,
protein processing in endoplasmic reticulum, and antigen processing and presentation. This suggests
that most proteins in the pink module can participate in anti-infection processes. The top 30 proteins that
showed the highest gene significance for T. gondii infection included HSP90AA1, PLCH1, SERPINA3-3,
HSPA4, GBP1, HSPCB, STIP1, TRIM21, HYOU1, HSPA5, ITGAL, PZP, GVIN1, PDIA3, ERAP1, C3,
SLA-DRA, LOC100513619, C4, GP91-PHOX, HSPH1, PLG, GBP7, STAT3, CASP1, HSP90B1, HSPA8,
PPIB, TAP1, and HSP70.2.
ITGAL (also known as CD11A) is expressed on antigen-experienced CD4+ and CD8+ T cells [41].
GBP1, GBP7, TRIM21, ERAP1, C3, C4, CASP1 and TAP1 have been confirmed as important anti-T. gondii
factors in mice or humans [31,33–35,39,45]. To further confirm whether the top 30 proteins are good
predictor of T. gondii infection, ROC analysis was performed. This analysis showed that all top
30 proteins are robust markers (AUC = 1) for prediction of T. gondii infection in the infected tissues
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(Figure 3). In general, host anti-T. gondii factors are upregulated during T. gondii infection. As shown in
Figure 5A, the proteins in the pink module were clustered into two branches, including 163 proteins in
the upregulated branch and 139 proteins in the downregulated branch. All the top 30 proteins were
clustered into the upregulated branch and most of them are protein chaperones involved in protein
quality control or MHC peptide process (Table 1). This finding is consistent with the fact that protein
quality control and antigen presentation pathways are important for host response against T. gondii
infection [32,33,39].
We further analyzed the functions of genes in both upregulated and downregulated branches.
As shown in Figure 6, the genes of the downregulated branch were significantly enriched in metabolism,
cell migration or interaction. However, genes of the upregulated branch were significantly enriched in
immune or infection related pathways. Therefore, genes in the upregulated branch were deemed as
PATPs. By analyzing the gene distributions on the pig genome, we identified two PATPs hotspots
in porcine chromosome 7. Most of the genes distributed in these two hotspots participate in antigen
presentation or other immune response related pathways (Table 2).
To determine the function of the identified PATPs, CRISPR-Cas9 method was used for the
construction of PDIA3- and HSP70.2-over-expressing cell lines. We selected two PATPs (PDIA3 and
HSP70.2) that showed high expression and were the hub proteins of the top 30 proteins, for the
construction of over-expressing cell lines. Our PCR and DNA sequencing results showed that PDIA3
and HSP70.2 over-expression cassette was correctly inserted into H11 locus, which is one of the safe
harbors in the pig genome (Figure 5C), although HSP70.2 cassette was only inserted into one H11 allele.
Western blot analysis showed that the HA tagging PDIA3 and HSP70.2 was correctly expressed in
the two over-expressing cell lines (Figure 5D). HSP70.2 and PDIA3 are two key proteins in antigen
presentation pathway and facilitate the antigen presented by MHC-I complex. As anticipated, HSP70.2
and PDIA3 over-expressing cell lines showed lower T. gondii loads compared with wild type 3D4/2
macrophages, particularly the PDIA3 over-expressing cells. Our study also showed that HSP70.2 and
PDIA3 can reach T. gondii (Figure 7), indicating that HSP70.2 and PDIA3 may facilitate T. gondii antigen
presentation and thereby contributing to limiting T. gondii replication within the host cells. Besides
HSP70.2 and PDIA3, we identified many other proteins that could potentially have anti-T. gondii
properties and can reveal novel mechanisms of host response against T. gondii infection in vivo.
5. Conclusions
The protein expression profile in the brain, liver, lung, spleen and MLNs of pigs during T. gondii
infection was investigated by iTRAQ technique. This proteomic analysis revealed > 100 DEPs in each
infected tissue. Immune responses were active across all infected tissues, whereas downregulated
metabolic processes were detected in infected livers, and vesicle mediated transportation was
upregulated in infected brains. Using trait correlation analysis, we identified 25 co-expression
modules and many PATPs. We also demonstrated that the swine macrophage cells overexpressing two
PATPs (HSP70.2 and PDIA3) showed enhanced resistance to T. gondii infection. Further elucidation
of the functions of other PATPs identified in this study will improve our understanding of how pigs
respond to T. gondii infection. Ultimately, this work can provide a solid foundation for the development
of disease-resistant pigs which could reduce the use of antiparasitic drugs in swine farms.
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